Veriskin develops the TruScore, a non-invasive handheld medical device that helps frontline and non-specialist caregivers assess suspicious skin lesions for cancer
Veriskin develops the TruScore, a non-invasive handheld medical device that helps frontline and non-specialist caregivers assess suspicious skin lesions for cancer. The device uses proprietary AI and real-time dynamic measurements of cutaneous hemodynamics to support faster, more objective screening and early detection while reducing false positives and unnecessary referrals.